Company
United StatesPaul Gerard Guy Richardson, M.D., Boston, MA – FDA Inspections
Inspection records and compliance data for Paul Gerard Guy Richardson, M.D. in Boston, Massachusetts. 4 FDA inspections on record, last inspected November 02, 2020.
Company Profile
This profile covers Paul Gerard Guy Richardson, M.D. based in Boston, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 0
- NAI
- 4
- Form 483s
- 0
- Warning letters
- 0
First inspected August 1, 2012. Last inspected November 2, 2020.
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 2, 2020 | NAI | Human Drugs · Bioresearch Monitoring | 1133642 |
| November 12, 2015 | NAI | Human Drugs · Bioresearch Monitoring | 949218 |
| September 8, 2015 | NAI | Human Drugs · Bioresearch Monitoring | 944249 |
| August 1, 2012 | NAI | Human Drugs · Bioresearch Monitoring | 795126 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Paul Gerard Guy Richardson, M.D.
FEI Number
3009620240
Address
Dana Farber Cancer Institute, 450 Brookline Ave, Boston, Massachusetts 02215, United States
Country
United States
ID: 89b4d5a4-f799-446b-a22d-3009e3743bc6